California State Teachers Retirement System (CalSTRS)’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
39,000
+22,077
+130% +$493K ﹤0.01% 1875
2026
Q1
$337K Sell
16,923
-235
-1% -$4.04K ﹤0.01% 2148
2025
Q4
$289K Buy
17,158
+15,017
+701% +$256K ﹤0.01% 2206
2025
Q3
$33.8K Buy
2,141
+6
+0.3% +$67 ﹤0.01% 2372
2025
Q2
$19.8K Buy
2,135
+709
+50% +$8.45K ﹤0.01% 2498
2025
Q1
$18.6K Hold
1,426
﹤0.01% 2552
2024
Q4
$24.8K Buy
+1,426
New +$29.7K ﹤0.01% 2537

Other funds holding BCAX

California State Teachers Retirement System (CalSTRS)'s BCAX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Bicara Therapeutics (BCAX) stake by 130% in Q2 2026, buying an estimated $493K and bringing the position to 39,000 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

California State Teachers Retirement System (CalSTRS) first reported a position in BCAX in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 39,000 shares of Bicara Therapeutics worth $1.16M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 22,077 Bicara Therapeutics shares in Q2 2026, an estimated $493K.
  • Bicara Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1875 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.